Cited by 105Pain Management and Opioid UseAnesthesia and Pain ManagementOpioid Use Disorder Treatment

The clinical analgesic efficacy of buprenorphine

Open access
Raffa, R. B., Haidery, M., Huang, H.-M., Kalladeen, K., Lockstein, D. E., Ono, H., Shope, M. J., Sowunmi, O. A. +2 more·2014·Journal of Clinical Pharmacy and Therapeutics

Abstract

WHAT IS KNOWN AND OBJECTIVE: Based on in vitro assays and select animal models, buprenorphine is commonly called a 'partial agonist'. An implication is that it should produce less analgesic effect in humans than so-called 'full agonists' such as morphine or fentanyl. However, buprenorphine has a multimechanistic pharmacology, and thus partial agonism at a specific receptor is not particularly relevant to its overall analgesic action. We review published clinical trials that directly compared the magnitude of buprenorphine's analgesic effect to analgesics commonly considered full agonists. COMMENT: Due to different signal transduction pathways, a drug can be a full agonist on one endpoint and a partial agonist on another. Therefore, we limited the present review to buprenorphine's analgesic effect. WHAT IS NEW AND CONCLUSION: Twenty-four controlled clinical trials were identified, plus a case report and dose-response curve. Based on complete or comparable pain relief, in buprenorphine had full clinical analgesic efficacy in 25 of the 26 studies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/jcpt.12196

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [5]5. Cowan A. Buprenorphine: new pharmaco- logical aspects. Int J Clin Pract Suppl, 2003;113:3-8; discussion 23-24.
  2. [6]6. Budd K, Raffa RB (Eds). Buprenorphine -the unique opioid analgesic. Stuttgart and New York: Thieme, 2005.
  3. [10]10. Raffa RB, Tallarida RJ. 'Affinity': historical development in chemistry and pharmacol- ogy. Bull Hist Chem, 2010;35:7-16.
  4. [14]14. Raffa RB, Pergolizzi JVJ. Is buprenorphine a 'partial agonist'? preclinical and clinical evidence. Pract Pain Manag, 2013;13: 33-39.
  5. [19]19. Cuschieri RJ, Morran CG, McArdle CS. Comparison of morphine and sublingual buprenorphine following abdominal sur- gery. Br J Anaesth, 1984;56:855-859.

Cited by

Sorted by citations

Authors
Raffa, R. B., Haidery, M., Huang, H.-M., Kalladeen, K., Lockstein, D. E., Ono, H., Shope, M. J., Sowunmi, O. A., Tran, J. K., & Pergolizzi, J. V.
Affiliations
  • Temple University (US)
  • Johns Hopkins University (US)
Corresponding author
Raffa, R. B.
Venue
Journal of Clinical Pharmacy and Therapeutics
Publisher
Wiley
Published
2014-07-29
Volume
39
Issue
6
Pages
577-583
ISSN
0269-4727 (ISSN-L)
OpenAlex
W2002790433
Cited by
105
References
46
Citations by year
2026: 9 · 2025: 11 · 2024: 8 · 2023: 17 · 2022: 5 · 2021: 12 · 2020: 12 · 2019: 12 · 2018: 9 · 2017: 4 · 2016: 4 · 2015: 1 · 2014: 1
FWCI
4.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Pharmacy and Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
  • Health Sciences › Medicine › Surgery › Anesthesia and Pain Management
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
Keywords
buprenorphine, analgesic efficacy, partial agonists, full agonists, morphine, fentanyl, opioid analgesics, analgesia, dose-response relationship, opioid receptor pharmacology
MeSH terms
Analgesics, Opioid, Animals, Buprenorphine, Dose-Response Relationship, Drug, Humans, Pain, Signal Transduction, Controlled Clinical Trials as Topic, Drug Partial Agonism

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review